US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pimco Total Return ETF

90.85

+0.28000.31%

Post-market: 90.55-0.3000-0.33%19:11 EDT

Volume:306.47K

Turnover:27.85M

Market Cap:5.49B

PE:- -

High:91.06

Open:90.86

Low:90.78

Close:90.57

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

SHO-BOND Holdings Co. Reports Steady Growth Amidst Financial Shifts

CG Oncology announces Phase 3 BOND-003 data presented at AUA meeting

CG Oncology Announces Best-in-Disease Durability Data in BOND-003 Cohort C and Promising Early Signal in Cohort P for Cretostimogene Grenadenorepvec at the American Urological Association Annual Meeting

CG Oncology to Host Conference Call and Webcast on BOND-003 Data on Monday, April 28, 2025

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BOND"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BOND","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BOND\",,,,,undefined,":{"symbol":"BOND","market":"US","secType":"STK","nameCN":"Pimco Total Return ETF","latestPrice":90.85,"timestamp":1746820800000,"preClose":90.57,"halted":0,"volume":306465,"hourTrading":{"tag":"盘后","latestPrice":90.55,"preClose":90.85,"latestTime":"19:11 EDT","volume":367,"amount":33252.55,"timestamp":1746832287556},"delay":0,"floatShares":60390000,"shares":60390000,"eps":0,"marketStatus":"Market Closed","change":0.28,"latestTime":"05-09 16:00:00 EDT","open":90.86,"high":91.06,"low":90.775,"amount":27846890.12595,"amplitude":0.003147,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1747036800000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":90.57,"sharesOutstanding":60390000,"nav":90.697424,"aum":5483621453.46,"dividendRate":0.051073,"bidAskSpread":0.000409,"preHourTrading":{"tag":"盘前","latestPrice":90.93,"preClose":90.57,"latestTime":"09:29 EDT","volume":691,"amount":62579.409595,"timestamp":1746797399370},"postHourTrading":{"tag":"盘后","latestPrice":90.55,"preClose":90.85,"latestTime":"19:11 EDT","volume":367,"amount":33252.55,"timestamp":1746832287556},"volumeRatio":0.9255126385966546,"impliedVol":0.0543,"impliedVolPercentile":0.42},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BOND\",,,,,undefined,":{"symbol":"BOND","floatShares":60390000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.9255126385966546,"shares":60390000,"dividePrice":4.64,"high":91.06,"amplitude":0.003147,"preClose":90.57,"low":90.775,"week52Low":88.9508,"pbRate":"--","week52High":95.32,"institutionHeld":0,"latestPrice":90.85,"eps":0,"divideRate":0.051073,"volume":306465,"delay":0,"ttmEps":0,"open":90.86,"prevYearClose":90.42,"prevWeekClose":90.87,"prevMonthClose":92.03,"prevQuarterClose":92.47,"fiveDayClose":90.87,"twentyDayClose":90.07,"sixtyDayClose":90.33},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/BOND\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BOND\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2534412926","title":"SHO-BOND Holdings Co. Reports Steady Growth Amidst Financial Shifts","url":"https://stock-news.laohu8.com/highlight/detail?id=2534412926","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534412926?lang=en_us&edition=fundamental","pubTime":"2025-05-09 15:14","pubTimestamp":1746774869,"startTime":"0","endTime":"0","summary":"SHO BOND Holdings Co ( ($JP:1414) ) has issued an announcement. SHO-BOND Holdings Co. reported a 4.8% increase in net sales for the nine months end...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sho-bond-holdings-co-reports-steady-growth-amidst-financial-shifts?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sho-bond-holdings-co-reports-steady-growth-amidst-financial-shifts?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SHO","US6M.BOND","US3Y.BOND","BK4588","BK4218","US12M.BOND","US2Y.BOND","US30Y.BOND","BK4181","US5Y.BOND","US7Y.BOND","US10Y.BOND","BK4585","BOND"],"gpt_icon":0},{"id":"2530657754","title":"CG Oncology announces Phase 3 BOND-003 data presented at AUA meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2530657754","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530657754?lang=en_us&edition=fundamental","pubTime":"2025-04-28 05:20","pubTimestamp":1745788821,"startTime":"0","endTime":"0","summary":"CG Oncology (CGON) announced that cretostimogene grenadenorepvec monotherapy data was presented at the Practice-Changing, Paradigm-Shifting Clinica...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cg-oncology-announces-phase-3-bond-003-data-presented-at-aua-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cg-oncology-announces-phase-3-bond-003-data-presented-at-aua-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B3QW5Z07.USD","IE00BGHQF748.EUR","BK4139","US3Y.BOND","CGON","IE00B64PRP62.GBP","BOND","BK4585","US30Y.BOND","US5Y.BOND","US7Y.BOND","CG","BK4135","US2Y.BOND","US10Y.BOND","BK4588","US6M.BOND","US12M.BOND"],"gpt_icon":0},{"id":"2530171196","title":"CG Oncology Announces Best-in-Disease Durability Data in BOND-003 Cohort C and Promising Early Signal in Cohort P for Cretostimogene Grenadenorepvec at the American Urological Association Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2530171196","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530171196?lang=en_us&edition=fundamental","pubTime":"2025-04-27 04:10","pubTimestamp":1745698200,"startTime":"0","endTime":"0","summary":"- Robust 24-month complete response rate of 42.3% by K-M for cretostimogene monotherapy in BOND-003 Cohort C –。- 58.3% of patients showed durable complete responses by K-M at 24 months –。- 97.3% of all treated patients remained free from progression to MIBC at 24 months–。- 91.6% of responders remained cystectomy-free at 24 months –。- No Grade 3 or greater treatment-related adverse events or deaths reported –。- Strong initial Cohort P data reported 90.5% high-grade recurrence-free survival at 3 and 9 months by K-M –。- Company will host a conference call and webcast at 8 a.m. EDT on Monday, April 28, 2025 -. IRVINE, Calif., April 26, 2025  -- CG Oncology, Inc. , a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients with bladder cancer, today announced that cretostimogene grenadenorepvec monotherapy data was presented at the Practice-Changing, Paradigm-Shifting Clinical Trials in Urology Plen","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cg-oncology-announces-best-disease-201000079.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4107","BK4585","US7Y.BOND","CGON","IE00BGHQF748.EUR","CR","US3Y.BOND","US6M.BOND","US10Y.BOND","BK4139","AFG","BK4135","US30Y.BOND","BK4588","BK4117","US2Y.BOND","BK4161","BCG","CG","BOND","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","US5Y.BOND","US12M.BOND"],"gpt_icon":0},{"id":"2529986685","title":"CG Oncology to Host Conference Call and Webcast on BOND-003 Data on Monday, April 28, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2529986685","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529986685?lang=en_us&edition=fundamental","pubTime":"2025-04-24 20:00","pubTimestamp":1745496000,"startTime":"0","endTime":"0","summary":"IRVINE, Calif., April 24, 2025  -- CG Oncology, Inc. , a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients with bladder cancer, today announced it will host a conference call and live webcast at 8:00 am ET on April 28, 2025, to discuss results from the Phase 3 BOND-003 trial of cretostimogene monotherapy in high-risk BCG-unresponsive non-muscle invasive bladder cancer  to be presented on April 26, 2025, at a Plenary Session at the American Urological Association  Annual Meeting in Las Vegas, Nevada.About Bladder CancerMore than 85,000 people are estimated to be diagnosed with bladder cancer in 2025. NMIBC is the most common form of bladder cancer, representing approximately 75% of newly diagnosed cases. Bladder cancer is the sixth most common form of cancer in the United States, and men account for three quarters of newly diagnosed cases.Cretostimogene is an investigational, intravesical","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cg-oncology-host-conference-call-120000320.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","US30Y.BOND","IE00B3QW5Z07.USD","CG","US6M.BOND","BK4218","BK4585","US7Y.BOND","BK4181","IE00BGHQF748.EUR","US10Y.BOND","HST","BOND","US3Y.BOND","BK4588","BK4135","IE00B64PRP62.GBP","US5Y.BOND","US2Y.BOND","CGON","BCG","US12M.BOND"],"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":12,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BOND\",params:#limit:5,,,undefined,":[{"date":"2025-05-01","symbol":"BOND","amount":0.4,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-01","defaultRemindTime":1746106200000,"name":"Pimco Total Return ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-05","payableDate":"2025-05-01","currency":"USD","dateTimestamp":1746072000000,"payDate":"2025-05-05"},{"date":"2025-04-01","symbol":"BOND","amount":0.38,"announcedDate":"2025-03-31","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-04-01","defaultRemindTime":1743514200000,"name":"Pimco Total Return ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-03","payableDate":"2025-04-01","currency":"USD","dateTimestamp":1743480000000,"payDate":"2025-04-03"},{"date":"2025-03-03","symbol":"BOND","amount":0.38,"announcedDate":"2025-02-28","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-03","defaultRemindTime":1741012200000,"name":"Pimco Total Return ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-05","payableDate":"2025-03-03","currency":"USD","dateTimestamp":1740978000000,"payDate":"2025-03-05"},{"date":"2025-02-03","symbol":"BOND","amount":0.39,"announcedDate":"2025-01-31","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-02-03","defaultRemindTime":1738593000000,"name":"Pimco Total Return ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-02-05","payableDate":"2025-02-03","currency":"USD","dateTimestamp":1738558800000,"payDate":"2025-02-05"},{"date":"2024-12-31","symbol":"BOND","amount":0.39,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-31","defaultRemindTime":1735655400000,"name":"Pimco Total Return ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-01-03","payableDate":"2024-12-31","currency":"USD","dateTimestamp":1735621200000,"payDate":"2025-01-03"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BOND\",market:\"US\",,,undefined,":[{"executeDate":"2015-05-29","recordDate":"2015-06-02","paymentDate":"2015-06-04","value":0.3,"currency":"USD"},{"executeDate":"2015-06-30","recordDate":"2015-07-02","paymentDate":"2015-07-07","value":0.3,"currency":"USD"},{"executeDate":"2015-07-31","recordDate":"2015-08-04","paymentDate":"2015-08-06","value":0.3,"currency":"USD"},{"executeDate":"2015-08-31","recordDate":"2015-09-02","paymentDate":"2015-09-04","value":0.37,"currency":"USD"},{"executeDate":"2015-09-30","recordDate":"2015-10-02","paymentDate":"2015-10-06","value":0.39,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BOND\",market:\"US\",delay:false,,,undefined,":{}}}